Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Multiple Cancer Types

The purpose of this study is to compare the effect of a blood thinning drug called Apixaban versus no administration of a blood thinning drug, in preventing blood clots in children with leukemia or lymphoma. Patients must be receiving chemotherapy, including asparaginase, and have a central line (a catheter inserted for administration of medications and blood sampling)
Pediatric Leukemia, Pediatric Lymphoma, Pediatric Supportive Care
III
Esbenshade, Adam
NCT02369653
COGACCL1333

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: